<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Zhang Y</submitter><funding>Huazhong Agricultural University</funding><funding>Hubei Province</funding><pagination>1568-1576</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9047237</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>226(9)</volume><pubmed_abstract>Isolated reports of new-onset diabetes in patients with coronavirus disease 2019 (COVID-19) have led researchers to hypothesize that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infects human exocrine and endocrine pancreatic cells ex vivo and in vivo. However, existing research lacks experimental evidence indicating that SARS-CoV-2 can infect pancreatic tissue. Here, we found that cats infected with a high dose of SARS-CoV-2 exhibited hyperglycemia. We also detected SARS-CoV-2 RNA in pancreatic tissues of these cats, and immunohistochemical staining revealed the presence of SARS-CoV-2 nucleocapsid protein (NP) in islet cells. SARS-CoV-2 NP and spike proteins were primarily detected in glucagon-positive cells, and most glucagon-positive cells expressed ACE2. Additionally, i</pubmed_abstract><journal>The Journal of infectious diseases</journal><pubmed_title>SARS-CoV-2 Infection Causes Hyperglycemia in Cats.</pubmed_title><pmcid>PMC9047237</pmcid><funding_grant_id>2020FCA046</funding_grant_id><funding_grant_id>2662020PY002</funding_grant_id><pubmed_authors>Zhao LZ</pubmed_authors><pubmed_authors>Wu C</pubmed_authors><pubmed_authors>Gao J</pubmed_authors><pubmed_authors>Huang K</pubmed_authors><pubmed_authors>Sun X</pubmed_authors><pubmed_authors>Zhao Y</pubmed_authors><pubmed_authors>Hu C</pubmed_authors><pubmed_authors>Zou Z</pubmed_authors><pubmed_authors>Yang Y</pubmed_authors><pubmed_authors>Zhang Y</pubmed_authors><pubmed_authors>Wang T</pubmed_authors><pubmed_authors>Jin M</pubmed_authors><pubmed_authors>Hui X</pubmed_authors><pubmed_authors>Chen X</pubmed_authors></additional><is_claimable>false</is_claimable><name>SARS-CoV-2 Infection Causes Hyperglycemia in Cats.</name><description>Isolated reports of new-onset diabetes in patients with coronavirus disease 2019 (COVID-19) have led researchers to hypothesize that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infects human exocrine and endocrine pancreatic cells ex vivo and in vivo. However, existing research lacks experimental evidence indicating that SARS-CoV-2 can infect pancreatic tissue. Here, we found that cats infected with a high dose of SARS-CoV-2 exhibited hyperglycemia. We also detected SARS-CoV-2 RNA in pancreatic tissues of these cats, and immunohistochemical staining revealed the presence of SARS-CoV-2 nucleocapsid protein (NP) in islet cells. SARS-CoV-2 NP and spike proteins were primarily detected in glucagon-positive cells, and most glucagon-positive cells expressed ACE2. Additionally, i</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Nov</publication><modification>2025-04-04T09:10:08.448Z</modification><creation>2025-02-19T03:58:52.494Z</creation></dates><accession>S-EPMC9047237</accession><cross_references><pubmed>35639863</pubmed><doi>10.1093/infdis/jiac143</doi></cross_references></HashMap>